larly memory, in postmenopausal women. Results are far from consistent. 2, 3, [6] [7] [8] In those studies showing a positive influence of estrogen on cognitive function, the effects are frequently observed on measures of verbal memory. 2 Recent advances in technology now permit the noninvasive measurement of brain function as individuals perform memory and other cognitive tasks. This technique, functional magnetic resonance imaging, exploits the differences in the magnetic properties of oxygenated compared with deoxygenated blood. In performing a cognitive task, such as working memory, blood flow and oxygen concentration are altered in those brain regions engaged by the task.
Neuroimaging studies examining the neural correlates of verbal memory have established a core set of expected patterns of functional activation observed at specific brain regions during the encoding, storage, and retrieval of to-beremembered materials. 9 For example, storage (or maintenance) of verbal material in working memory is typically associated with activations at anterior brain regions in the frontal lobe and at a more posterior region in the parietal lobe. 10 With respect to encoding and retrieval, an almost universally obtained result is a relatively greater left-frontal hemisphere activation during encoding 11, 12 and a relatively stronger right-frontal hemisphere activation during retrieval, a pattern designated as the hemispheric encoding/retrieval asymmetry (HERA) effect. 13 We used functional magnetic resonance imaging to determine whether estrogen treatment in postmenopausal women modified these expected brain activation patterns.
METHODS

Subjects
We studied 46 postmenopausal righthanded women between the ages of 33 and 61 years (mean [SD] age, 50.8 [4.7] years) in a randomized, double-blind, placebo-controlled, crossover trial. Women were recruited for a study examining "the role of estrogen in cognitive processes" through postings in libraries, letters to women's groups and physicians' offices, and newspaper advertisements. Informed consent was obtained from all subjects. Subjects were compensated $250 for their participation. Entry criteria consisted of having good general health, being right handed, having normal structural magnetic resonance imaging findings, having an IQ of at least 85, and having last menstrual period at least 5 months before entering the trial; exclusion criteria were having follicle-stimulating hormone levels of 45 IU/L or less and estradiol levels that were at least 128 pmol/L at baseline. Subjects had received no exogenous hormones for at least 3 months before entry.
Intervention
Women were treated for 2 periods of 21 days each, 1 with conjugated equine estrogens (1.25 mg/d) and the other with identical placebo with 14 days of washout between treatments. Subjects were randomized to start treatment with estrogen or placebo; the randomization scheme was generated using a random number table in blocks of 4. Eligible participants were assigned the next available sequential randomized treatment assignment. The randomization scheme was in the sole possession of the Investigational Drug Service of the Yale-New Haven Hospital Pharmacy, New Haven, Conn; hence, study personnel and subjects remained blinded to treatment assignment throughout. Study medication, or placebo, consisted of 1 tablet daily containing conjugated estrogens, 1.25 mg, or identical-appearing white placebo tablets. Compliance was monitored by weekly contacts with the project nurse, pill counts at the termination of each phase, and serum samples at the end of each 21-day period for estrone, estradiol, equilin, and dihydroequilin.
Forty-seven women were randomized to the protocol; 1 subject was found to have a large cystic abnormality during the first imaging session. Although she completed the protocol, the structural brain abnormality precluded analysis of the functional data. Functional imaging data were thus available for 46 subjects. The primary analyses reported herein are on all 46 women, constituting a modified intention-to-treat analysis. The nature of the study mandated that the serum hormone levels not be disclosed until the study was complete. At that time, 10 subjects were identified as not meeting the inclusion or exclusion criteria because they were nonmenopausal based on their follicle-stimulating hormone and estradiol concentrations (n = 6, 1 of whom also had a low IQ), 1 was not healthy, based on abdominal surgery (laparoscopic cholecystectomy with anesthesia) during the 14-day washout period; and 3 were noncompliant based on serum equilin levels of less than 200 pg/mL during the estrogen phase. An additional analysis was performed on this subset of 36 sub- The components of each cycle, encode, store, retrieve (forced choice recognition), and rest, were each 20 seconds long. Each run alternated between verbal and nonverbal cycles. A, For the verbal cycle encode phase subjects saw 5 nonsense words sequentially for 4 seconds each, followed by a 20-second storage period with nothing on the screen. During the retrieval period, subjects saw 2 familiar nonsense words and 2 new nonsense words. B, For nonverbal cycles, subjects saw 3 Tamil characters for 6.67 seconds each, followed by a 20-second storage period. During the retrieval period, subjects saw 2 familiar characters and 2 new Tamil characters.
jects who satisfied inclusion and exclusion criteria.
Imaging
Subjects underwent imaging in a 1.5-T Signa MR imaging system (General Electric, Waukesha, Wis) equipped with echo-planar imaging hardware (Advanced NMR, Wilmington, Mass). Women lay supine in the imaging system, looking up through a periscope at a screen that was attached to the gantry; stimuli were projected on the screen with a Macintosh laptop computer (Apple Computer, Cupertino, Calif). Stimuli for the verbal memory tasks were pronounceable nonsense words, and for the nonverbal memory tasks were Tamil letters (for non-Tamil speakers these characters are coded as complex geometric patterns). The protocol is shown in FIGURE 1.
Image Analysis
We used 2 parallel types of data analyses, both with the goal of identifying brain areas showing estrogen effects and/or estrogen interactions with task (encode, store, retrieve) and stimulustype (nonsense words or Tamil). In 1 approach, analyses were performed on a voxel-by-voxel basis. Effect sizes were computed using standard linear contrasts, which represent differences in mean activation levels between 1 set of experimental conditions and another set. The associated significance levels (␣ = .05) were assessed using a nonparametric randomization test 14 and overlaid on the mean anatomic image for display; we refer to these maps of complex effects as contrast maps (FIGURE 2 and  FIGURE 3 ). The other type of analysis, termed a region of interest analysis, [15] [16] [17] operates on relatively large brain areas and focuses on brain regions that previous research has implicated in memory, for example, superior frontal and parietal sites.
RESULTS
Subjects
The 46 subjects had a mean IQ of 99.0 (range, 74.8-127), mean last menstrual period of 34.3 months (range, 5-168 months; median, 16.0 months), mean follicle-stimulating hormone levels of 78.6 IU/L (range, 4.1-150 IU/L), and mean estradiol levels of 108 pmol/L (range, 55.1-348.7 pmol/L). Thirtyfive subjects (76%) were actively employed outside the home. Subjects had received no exogenous hormones for at least 3 months before entry.
Brain Activation Patterns
Estrogen produced significant modifications in expected brain activation pat- terns in a number of brain regions. During the verbal store task (Figure 2 ), estrogen increased activation in the inferior parietal lobule and the superior frontal gyrus. Region of interest analyses confirm this pattern; significant condition ϫ stimulus-type ϫ task interactions were obtained for both the inferior parietal lobule (F 2,90 = 7.359; PϽ.025) and the superior frontal gyrus (F 2,90 = 6.237; PϽ.01). As illustrated for the inferior parietal lobule in FIGURE 4, increases in activation from the placebo to the estrogen condition were specific to the verbal store task. Estrogen also produced a sharpening of the hemispheric encoding/ retrieval asymmetry effect. For example, strong increases in activation were found in the right superior frontal gyrus during the retrieval tasks, both for verbal and nonverbal stimuli (Figure 3) . Region of interest analyses were consistent and indicated that the left hemisphere showed greater activation than the right hemisphere during encoding, and the right hemisphere showed greater activation than the left hemisphere during retrieval, the hemispheric encoding/retrieval asymmetry effect. These results were further modified by significant 3-way interactions (condition ϫ task ϫ hemisphere interaction at the superior frontal gyrus, F 2,90 = 4.055; PϽ.025), which demonstrated that the hemispheric encoding/ retrieval asymmetry effect was much more pronounced in the estrogen condition (Figure 4) . The effects described above, both for the voxel-by-voxel and for the region of interest analyses, were also examined for the subset of subjects who satisfied inclusion and exclusion criteria and who were compliant (n = 36). The pattern of results did not change.
Accuracy of retrieval of information did not differ between the estrogen and the placebo condition for either the verbal or nonverbal stimuli (FϽ1; mean proportion correct was 0.912, 0.923, 0.914, and 0.930 for the verbal placebo, nonverbal placebo, verbal estrogen, and nonverbal estrogen, respectively).
COMMENT
The results of this study indicate that estrogen in a traditionally prescribed therapeutic dose produces significant alterations in brain activation patterns in postmenopausal women as they perform working memory tasks. These data suggest that it may be possible to affect functional brain organization in older women; these alterations in brain activation patterns in subjects taking estrogen suggest functional plasticity of memory systems in mature women.
Our experimental study was theoretically driven, guided by our prior experience with studying the process of reading. Reading is known to rely on a component of language, phonologic processing, which relates to the sound structure of language. 18 A large body of research indicates that phonologic processes are also strongly involved in verbal working memory 19, 20 and that verbal information is typically held in temporary storage in its phonologic form. We further observed that the components of language and memory often reported to be sensitive to the actions of estrogen (eg, verbal working memory, articulatory speed, and verbal fluency) 21, 22 have in common a reliance on phonologic processing. Accordingly, we hypothesized that estrogen may exert a positive influence on language and memory through its actions on phonologic mechanisms and, for this study, we chose a set of verbal tasks that specifically engaged phonologic systems. Women treated with estrogen demonstrated increased activation in the inferior parietal lobule during tasks requiring temporary storage of phonologically coded verbal materials (nonsense words). This response provides support for the hypothesis that estrogen mediates the short-term storage of phonologic material. Our findings in the inferior parietal lobule are reinforced by a recent report by Jonides et al, 10 who studied both men and women and found that activation in the inferior parietal region occurred during the short-term storage and retrieval of phonologic stimuli. The results support our hypothesis that estrogen effects may be mediated through its actions on neural sites serving phonologically coded materials.
However, our findings also indicate that the effects of estrogen are not limited to verbal memory. For example, we observed a sharpening of the HERA effect in the superior frontal gyrus that was present on nonverbal as well as verbal tasks. These findings of effects on nonverbal memory are consistent with the findings of Resnick and associates 23 that show effects of estrogen on a visual memory task. Although many studies of estrogen, either across the menstrual cycle 24 or in postmenopausal women, 25, 26 demonstrate an effect on verbal memory, for the most part, these studies do not include nonverbal stimuli. 23 The notion that estrogen exerts an influence on nonverbal as well as verbal memory systems is consonant with observations that estrogen exerts its actions on neural systems distributed throughout the brain. 27, 28 An intriguing finding in the current study is that changes in brain activation patterns in frontal regions noted above for the estrogen-treated womengreater left-hemisphere activation during encoding and greater righthemisphere activation during retrievalappear similar to patterns observed in younger subjects compared with older ones in previous studies. 29, 30 In addition, older subjects show increased activation in insula relative to younger subjects and in our study estrogen was associated with decreased activation in this region (Figure 2, B; Figure 3 , C). We note that despite the estrogeninduced differences in brain activation patterns, error rates on each task were comparable between conditions. Brain activation patterns have been shown to be more sensitive than behavioral measures in some conditions. For example, functional imaging may detect brain activation pattern differences in patients at high risk for Alzheimer disease before behavior deficits are evident, 31 and Cabeza and associates 29 found that older and younger subjects demonstrated age-related differences in brain activation patterns despite comparable behavioral performance. Based on our findings, we suggest that functional imaging techniques may detect effects of estrogen on the brain that are not yet demonstrable by behavioral measures themselves. This study has many strengths, including the randomized, doubleblind, placebo-controlled, crossover design, a large sample size for an imaging study, and tasks that assess verbal and nonverbal memory. We relied on a theoretic framework incorporating both phonologic processing and working memory to systematically assess the effects of estrogen on different components of both verbal and nonverbal working memory and incorporated nonsense words so that we were able to examine phonologic processes specifically. A limitation of this study was the relatively brief time that women were receiving either estrogen or placebo and the relatively short washout period between conditions. Although this treatment period may have been too short to produce significant behavioral effects, our findings suggest that it was sufficiently long to demonstrate an effect using functional imaging as a sensitive index of brain function. Furthermore, as indicated by the minimal error rates, the relative ease of performance of the memory tasks may have precluded detection of differences between the estrogen and placebo conditions ("ceiling" effect).
There are many considerations that enter into a woman's decision about whether to take hormone replacement therapy. Acknowledgment and understanding of the effects of estrogen on the skeletal and cardiac systems have progressed considerably, although new data continue to modify our knowledge. 31, 32 The influence of estrogen on cognitive function has been much more difficult to establish. As Barrett-Connor 33 recently indicated, there is no question of the biological plausibility for a beneficial effect of estrogen on brain function, yet the studies to date in postmenopausal women are inconsistent. Lack of clarification of estrogen's role in cognition has been a source of particular frustration for postmenopausal women, in part because the symptoms are often subtle yet may have pervasive effects on the quality of life.
This current study demonstrates that estrogen alters brain activation patterns in postmenopausal women and its corollary that functional brain organization in mature women (and, we assume, men) is neither fixed nor immutable. These changes in brain activation patterns (1) are observed in specific brain regions associated with the sorts of memory function that are called on frequently during any given day (for example, trying to remember a telephone number that had been just looked up); and (2) appear to reinstate patterns typically observed in younger, but not older, subjects as they perform memory tasks. While we believe the changes in brain organization should predict accompanying improvements in performance of memory tasks, we caution that in this study we did not observe such changes during the study period. However, these data suggest that estrogen affects brain organization in postmenopausal women. In addition, functional imaging may provide a new tool to detect these effects of estrogen. These results are encouraging and suggest that the use of functional imaging together with protocols examining, for example, different dosages, treatment lengths, and washout periods, may provide a new means to explore the effects of estrogen on cognitive function in postmenopausal women.
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